Mount Vernon’s new £1.43 million chemotherapy trial centre one step closer

Northwood, UK – 23 July 2008 – A new £1.43 million chemotherapy research trial facility – which is being supported by the Cancer Treatment and Research Trust (CTRT) – is one step closer to being built at the Mount Vernon Cancer Centre. This follows consideration of a business case at a recent meeting of the Trustee of the East and North Hertfordshire NHS Trust Charitable Fund (known more commonly as enhance herts), which has been leading the fundraising efforts on this important project, through its CTRT Appeal.
In order to meet the needs of increasing numbers of patients and updated regulatory requirements for conducting clinical trials, the cancer centre’s current facilities need to be overhauled completely. The proposal is for the existing facility to be renovated and expanded so that patients undergoing chemotherapy trials, as well as those receiving standard treatments, will be cared for in state-of-the-art surroundings.
The chief executive of the East and North Hertfordshire NHS Trust, Nick Carver, welcomed the announcement: “The decision by the Trustee of enhance herts to approve the business case in principle, subject to all outstanding issues being resolved by its next meeting in September 2008, enables us to keep momentum going on this important project for the Mount Vernon Cancer Centre’s continued development. This means that we can carry on with the design work that is underway already and seek tenders to build the new facility – which we are aiming to open during mid-2009, subject to final approval being received.
2/Mount Vernon’s new £1.43 million chemotherapy trial centre one step closer
“This important project is just the latest in a series of major investments in the Mount Vernon Cancer Centre that have been managed by the Trust. In September 2006, a new £2.25 million brachytherapy unit – which provides specialist radiotherapy for diseases such as prostate cancer – was opened to patients. Just six months later in March 2007, the £21.82 million New Radiotherapy Wing began treating its first patients.
“Assuming there is no delay in the building of the new chemotherapy trials facility, £25.5 million of combined NHS and charitable investment will have been pumped in to Mount Vernon since the Trust took over the running of the cancer centre in April 2005. This has helped us not just to improve the range and quality of care provided to patients, but importantly also the environment in which they are treated. While there is more to be done still, many of the centre’s facilities have been transformed.”
Professor Gordon Rustin, who is a director of medical oncology at the Mount Vernon Cancer Centre and has been at the heart of plans to develop its chemotherapy trial facilities, said: “I am very pleased that the new unit is a step closer to being built. I and my colleagues – with the welcome support of the Cancer Treatment and Research Trust in particular – have been working hard to deliver this vital project.
“With our fundraising efforts continuing, we are confident that all the money needed to deliver the new unit will be raised. The real heroes of the CTRT Appeal are the cancer patients who formed the appeal committee, as well as the thousands of former patients who have made donations – both big and small.”
The proposed new chemotherapy trials facility at Mount Vernon will include:
· an area, comprising 16 treatment chairs and two beds, for treating up to six patients taking part in clinical trials and a maximum of 12 receiving standard chemotherapy;
· three consulting rooms for the examination of patients, undertaking clinical procedures, follow-up appointments and private discussions with patients and/or their families or carers;
3/Mount Vernon’s new £1.43 million chemotherapy trial centre one step closer
· one counselling room for consultations that may involve breaking distressing news to patients;
· two prep areas for laying up trolleys for phlebotomy and chemotherapy administration, as well as checking drugs;
· more space for research nurses who are monitoring patients taking part in clinical trials;
· better facilities for research data and sample processing.
· enlargement of the waiting room area to accommodate the increasing numbers of patients using the facility, along with their relatives and/or carers – including views of, and access to, landscaped gardens;
To date, after costs, £1.11 million has been raised through a combination of funds received and pledged, with an additional £300,000 underwritten funding available should it be needed. The current timelines see final business case approval being received in September 2008, subject to all outstanding issues being resolved to the satisfaction of the Trustee of enhance herts. The tendering process, which will commence shortly, should result in a contractor being appointed in October 2008, with construction starting the following month. If this timetable is delivered, then this would see the unit opening to patients from April 2009.

